FIGURE

Fig. 2

ID

ZDB-FIG-230127-18

Publication

Tang Gundersen et al., 2021 - Repurposing chlorpromazine for anti-leukaemic therapy by nanoparticle encapsulation

Other Figures

All Figure Page

Back to All Figure Page

Fig. 2

CPZ exhibits synergistic activity with several anti-AML drugs. MOLM-13 cells were incubated for 24 h with CPZ (10 �M) alone, or with either EME (50 or 120 nM) (A) or VPA (1.0 or 1.5 mM) (B) and viability measured by metabolic conversion of the WST-1 reagent. (C): Coefficient of drug interaction (CDI) was calculated as described in the Methods section (see Eq. (5)). A CDI < 1 indicates synergism, a CDI = 1 indicates additivity, and a CDI > 1 indicates antagonism. Results are from a triplicate experiment. Asterisks *, **, and *** indicate p ? 0.05, ? 0.01, and ?0.001, respectively, from ANOVA Oneway (Bonferroni) statistical analysis (A,B) and one-sample two-sided t-test (C).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int J Pharm